Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS) 2019-11-07 14:43
FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays 2019-11-07 12:00
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma 2019-11-07 11:02
First Asia-Pacific hospital treats patients with RayStation and Radixact 2019-11-07 09:00
AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences 2019-11-07 08:01
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S. 2019-11-07 05:14
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364 2019-11-07 01:40
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019 2019-11-07 01:00
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports 2019-11-06 18:01
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation 2019-11-06 17:21
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies 2019-11-06 16:00
Olympus Unveils Corporate Strategy 2019-11-06 14:08
15 Years of P-MEC China Driving Global Pharma Technology Forward in China 2019-11-06 14:00
Wiley Partners With Editage to Enhance and Expand Services for Authors 2019-11-06 11:00
Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019 2019-11-06 05:05
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab) 2019-11-05 21:00
Cognate BioServices announces acquisition of Cobra Biologics 2019-11-05 12:32
Farrer Park Hospital Introduces High Intensity Focused Ultrasound (HIFU) Treatment for Uterine Fibroid in Singapore 2019-11-05 09:00
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
1 603 604 605 606 607 953